For patients who had cancer and autopsy-proven pneumonia, we evaluated whether cultures of respiratory secretions (sputum and/or bronchoalveolar lavage) performed р4 weeks before autopsy were a reliable basis for the diagnosis of pulmonary candidiasis. Pulmonary candidiasis was identified at autopsy in 36 patients, but common clinical predictors were insensitive for this diagnosis. For sputum culture, the sensitivity, specificity, and the positive and negative predictive values were 85%, 60%, 42%, and 93%, respectively; for bronchoalveolar lavage culture, these values were 71%, 57%, 29%, and 89%, respectively.
For patients who had cancer and autopsy-proven pneumonia, we evaluated whether cultures of respiratory secretions (sputum and/or bronchoalveolar lavage) performed р4 weeks before autopsy were a reliable basis for the diagnosis of pulmonary candidiasis. Pulmonary candidiasis was identified at autopsy in 36 patients, but common clinical predictors were insensitive for this diagnosis. For sputum culture, the sensitivity, specificity, and the positive and negative predictive values were 85%, 60%, 42%, and 93%, respectively; for bronchoalveolar lavage culture, these values were 71%, 57%, 29%, and 89%, respectively.
The diagnosis of pulmonary involvement of Candida species is difficult [1] [2] [3] [4] [5] [6] . Our understanding of the frequency and pathogenesis of Candida pneumonia remains limited to indirect data collected from a relatively small number of reports [1] . Pulmonary candidiasis (PC) in patients with cancer occurs in 2 settings: in cases of aspiration pneumonia in patients who are heavily colonized by Candida species in the oral cavity (primary Candida pneumonia), or as part of disseminated candidiasis [1] [2] [3] . On the other hand, Candida colonization in the upper respiratory tract is quite common in patients with cancer [4] . Therefore, cultures of samples obtained from the respiratory tract, including sputum and even bronchoalveolar lavage (BAL), that are positive for Candida species cannot be the sole basis for a diagnosis of invasive pulmonary infection with Candida species [1] .
Making a convincing diagnosis of Candida pneumonia is only truly possible on the basis of histopathologic examination of samples [1] . However, invasive pulmonary procedures are problematic in patients with cancer. Hence, clinicians commonly face a dilemma: determining the significance of a sputum or BAL culture that is positive for Candida species in a patient with cancer. There is a paucity of literature on this issue [4, 5, 7] . Therefore, we conducted a 5-year autopsy study to address this problem and identify whether there are any clinical parameters that indicate the diagnosis of PC in this patient population.
Methods. We identified patients with cancer who underwent autopsy at the University of Texas M. D. Anderson Cancer Center from 1 January 1995 through 31 December 1999. Patients without histopathologic evidence of pneumonia were excluded. Patients with pneumonia and a matched sputum culture, BAL culture, or both within 4 weeks before autopsy were included in the analysis. The patients' medical records were reviewed for underlying disease, recovery of another respiratory pathogen, radiologic findings, BAL cytologic findings, Candida species isolated from sputum specimens, BAL specimens, and identification of Candida species in a culture of a specimen obtained from another sterile site (e.g., blood or tissue) at autopsy or р30 days before death.
All samples (premortem and postmortem) were submitted to our microbiology laboratory and routinely plated on Sabouraud dextrose plates, Mycosel agar (BBL), Sabouraud dextrose slanted test tubes, and brain-heart infusion/10% sheep blood agar with chloramphenicol and gentamicin. Candida species were identified with use of the API 20C system (Analytab Products) and confirmed by means of microscopic examination for characteristic morphology. BAL was performed with use of a bronchoscope and 60-200 mL of a sterile saline solution in 20-30 mL aliquots. A portion of the BAL fluid was sent to the clinical laboratory for bacterial, viral, fungal, and mycobacterial stains and cultures; the remaining BAL fluid was centrifuged at 500 g for 10 min, and the sediment was smeared and stained for identification of fungi with use of Gomori's methenamine silver stain. Cytologic examination of the sputum cultures was not routinely performed. No quantitative cultures of respiratory secretions were performed in our institution.
For autopsy-proven cases of PC, we required microscopic demonstration of yeast invasion in tissue samples taken from a compatible macroscopic lesion. Histologic samples were stained with hematoxylin and eosin and Gomori's methenamine silver. If destruction of alveolar structures and inflammation without the presence of an identifiable organism was demonstrated, the diagnosis of nonspecific pneumonitis was made. BAL and bronchial washing specimens were analyzed separately, and similar morphological criteria were used for the cytologic specimens. Categorical data were analyzed by x 2 or Fisher's exact test.
was considered significant. P р .05 Results. A total of 676 patients with cancer underwent autopsy during the study period. Of those, 254 patients (38%) had histopathologic evidence of pneumonia. Histologically proven PC was diagnosed in 36 (14%) of these 254 patients. A total of 146 patients with pneumonia at autopsy had matching sputum cultures (110 patients) and/or BAL cultures (85 patients) performed during the preceding 4 weeks and were analyzed further. For 5 patients, autopsy was limited to the chest. Of the remaining 31 patients with PC, 13 patients (42%) had evidence of disseminated candidiasis; 1 patient who did not have PC had a kidney abscesses due to Candida krusei. Ten (77%) of 13 patients with disseminated candidiasis involving the lungs had a underlying hematologic malignancy. A comparison of some clinical parameters of the patients who had and patients who did not have PC is shown in table 1. Sputum cultures, BAL cultures, or both that were positive for Candida species were seen in 30 (83%) of the 36 cases of PC. However, they were also seen in 46% of the cases without histopathologic evidence of PC at autopsy ( ). Also, when Candida were P p .08 identified at the species level, the concordance between the Candida species identified in premortem and postmortem cultures was 100% for sputum culture and 89% for BAL culture. In addition, cultures positive for non-albicans species of Can- dida were common both for patients with autopsy-proven PC (57%) and in patients without it (64%). Similarly, the presence of a concomitant fungal or bacterial respiratory pathogen did not differentiate the 2 cohorts (table  1) . Both groups had a high frequency of other respiratory pathogens. Concomitant lung infection in patients with PC were mainly polymicrobial. Pathogens found in the respiratory tract р30 days before death included gram-positive cocci in 8 patients (Enterococci species, 4 patients; coagulase-negative staphylococci and Staphylococcus aureus, 2 patients each), gramnegative rods in 5 patients (Escherichia coli, 2 patients; Enterobacter aerogenes, Klebsiella pneumoniae, and Pseudomonas species, 1 patient each), and molds in 11 patients (Aspergillus terreus and Aspergillus flavus, 3 patients each; Aspergillus species, 2 patients; and A. fumigatus, Rhizopus species, and Scedosporium species, 1 patient each). Thirty-nine (35%) of 110 control patients had histopathologic documentation of invasive lung infection with other fungal species (molds in 36 patients [92%]). In these patients, the presence of Candida species in the respiratory tract was considered to be colonization. Similarly, patients with PC and patients without PC could not be differentiated on the basis of the findings of radiologic studies of the lungs (table 1) . No patient with PC had normal findings on a chest radiograph. Multilobar consolidation was the most common radiographic pattern for patients with PC. The sensitivity, specificity, and positive and negative predictive value for the sputum and BAL culture respectively are shown in table 2. The addition of cytologic analysis did not change the predictive value (data not shown).
Discussion. To our knowledge, no previous studies have attempted to systematically evaluate the diagnostic value of premortem cultures of respiratory secretion samples (sputum or BAL) for detection of Candida species by comparing them with the gold standard, histopathologic demonstration of tissue invasion by yeasts. Our findings are in agreement with those of a previous study by Masur et al. [4] , which showed that sputum and BAL cultures positive for Candida species are common for patients with cancer but their specificity and positive predictive value are low. However, the results of our study appear to disagree with those of a small study by Saito et al. [5] , which suggested that a BAL culture positive for Candida species, when performed late (р72 h before death), accurately predicts the presence of PC in a selected group of patients with leukemia and fatal pneumonia. However, our study, which included 19 patients who had a hematologic malignancy, did not examine the same clinical scenario. The low specificity and positive predictive value of sputum and BAL cultures for our patient population are similar to those seen for other groups, such as patients in intensive care units [2, 6] . Therefore, histologic diagnosis of PC, used alone, may provide a useful reference criterion for future comparisons of culture methods or other diagnostic techniques. However, in view of the high negative predictive value of sputum and BAL cultures, it is reasonable to conclude that the absence of Candida species in a culture of respiratory secretions obtained from a patient with cancer should assure the clinician that the possibility of PC is unlikely. Finally, our experience suggests that common clinical predictors continue to be insensitive indicators for diagnosing this rare entity in patients with cancer [4] . To date, few data are available on the Candida species that cause PC [1] . It is of note that in our series, the various non-albicans species of Candida did not appear to be more likely to cause PC than is Candida albicans.
Our study had several limitations. First, we did not examine other potentially important clinical parameters, such as the presence of neutropenia, use of systemic steroids, and histologic patterns in our selected but heterogeneous group of patients with cancer. In addition, we did not examine the diagnostic usefulness of sputum culture or BAL culture in patients who had cancer and pneumonia and did not die or undergo postmortem examination. Furthermore, we did not determine whether the presence of PC at autopsy was clinically significant or just an incidental finding. The autopsy finding of PC that did not contribute to death has been reported in large autopsy studies of patients with cancer [7] [8] [9] .
